Gut Microbiota Diversity: Wrong Message in Autism, Wrong Architecture in Formation
Microbiota-Diversity Enhancing Diet on Children With Autism Spectrum Disorder: The MIND-DASE Study
1 other identifier
observational
320
1 country
1
Brief Summary
Our dietary diversity has changed day by day in industrial age. A low dietary diversity may alter gut microbiota diversity and functional capacity. Wrong messages sourced from gut microbiota were speculated to have a bad influence on autism spectrum disorder (ASD) severity. A new nutritional model aiming to increase microbiota diversity in children with ASD can improve social and communicative behaviors in these children. The investigators compared 220 ASD patients who regularly followed a specific diet program for at least 12 months with randomly selected 100 children with ASD who did not have diet compliance in terms of nutritional status and regular behavioral assessments with special scales (ATEC, ABC, QoLA-P scales). The investigators arised a question that the Microbiota-Diversity Enhancing Diet on Children with ASD (MIND-DASE) which is a specific dietary intervention may have benefits on the neurodevelopmental outcomes of children with ASD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedFirst Submitted
Initial submission to the registry
October 17, 2024
CompletedFirst Posted
Study publicly available on registry
October 29, 2024
CompletedOctober 29, 2024
October 1, 2024
6 years
October 17, 2024
October 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in ATEC scores in diet (study) and non-diet (control) ASD participants from baseline to 1 year period.
ATEC scores will be evaluated by a specialist psychiatric nurse in both groups. ATEC is a parent-completed questionnaire and has four subscales. A total score, which ranges from 0-179 points, is calculated from combined scores of each subscale. A lower ATEC score indicates improvement of ASD symptoms and a higher score correlates with more severe symptoms.
From enrollment to the end of 12-month time period
Changes in ABC scores in diet (study) and non-diet (control) ASD participants from baseline to 1 year period.
ABC scores will be evaluated by a specialist psychiatric nurse in both groups. ABC is a scale for determining the behavioral problems in ASD children. It consists of 5 subscales and 58 items. Each item is rated on a four-point scale ranging from 0 (not a problem) to 3 (the problem is severe). Evaluation is based on the scores obtained from the subscales; minimum 0 points to maximum 174 points.
From enrollment to the end of 12-month time period
Changes QoLA-P scores in diet (study) and non-diet (control) ASD participants from baseline to 1 year period.
The QoLA-P scores will be evaluated by a specialist psychiatric nurse in both groups. QoLA-P is designed as two subscales: Section A evaluates parent's perceptions about their own QoL, and section B measures the perceptions of parent's problems lived with an autistic child. Total score from this questionnaire ranges from 48 to 240 and higher scores show lesser severity effect.
From enrollment to the end of 12-month time period
Secondary Outcomes (2)
Height status in diet and non-diet group
From enrollment to the end of 12-month time period
Weight status in diet and non-diet group
From enrollment to the end of 12-month time period
Other Outcomes (1)
Observation of eating pattern
From enrollment to the end of 12-month time period
Study Arms (2)
220 ASD cases regularly followed our specific diet
220 individuals who regularly followed our specific diet program for at least 12 months were identified as a study group.
100 ASD cases who did not have diet compliance
100 children with ASD who did not have diet compliance were identified as control group.
Interventions
Microbiota-Diversity Enhancing Diet on Children with ASD (MIND-DASE) suggested that increasing microbiota diversity through dietary interventions can have significant benefits on the neurodevelopmental outcomes of children with ASD
Eligibility Criteria
You may qualify if:
- Individuals who were diagnosed ASD by a pediatric psychiatrist or a pediatric neurologist according to the DSM-V criteria
- Having continued follow-up in our center at least 12 months regularly
- Being between the ages of 2-18
You may not qualify if:
- Having a genetic syndrome (such as Rett, Angelman syndrome)
- Having an additional chronic disease
- Following a different diet program other than our center
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Basakşehir Cam & Sakura City Hospital, Autism Nutrition and Research Center
Istanbul, Basaksehir, 34480, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof M.D.
Study Record Dates
First Submitted
October 17, 2024
First Posted
October 29, 2024
Study Start
January 1, 2017
Primary Completion
December 30, 2022
Study Completion
December 30, 2022
Last Updated
October 29, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share